
Please try another search
Investing.com - U.S. stock futures soar following the unveiling of a substantial lowering in tariffs between the U.S. and China. The deal helps to underpin optimism for a softening in a recent trade...
AstraZeneca PLC (LSE/STO/Nasdaq:LON:AZN), a global biopharmaceutical company, has announced its total number of voting rights as of April 30, 2025. In a regulatory filing with the Securities and...
Investing.com -- AstraZeneca (LON:AZN) (ST:AZN) shares fell more than 3% Tuesday after the drugmaker missed first-quarter revenue expectations, with underperformance in key cancer and respiratory...
Investing.com -- Barclays (LON:BARC) on Monday revealed its second-quarter U.K. stock picks for 2025, assigning Overweight ratings to six U.K. stocks and Underweight ratings to two. The stocks...
Investing.com -- AstraZeneca (NASDAQ:AZN), a leading pharmaceutical company, announced on Monday that it plans to acquire biotechnology firm EsoBiotec in a deal that could reach up to $1...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review